Streptokinase biosimilar (Chandra Bhagat Pharma)

链激酶生物类似药 (Chandra Bhagat Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStreptokinase biosimilar (Chandra Bhagat Pharma)
Drug Alias Name链激酶生物仿制药 (Chandra Bhagat Pharma)Streptoken
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsCardiovascular Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/08/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChandra Bhagat Pharma(Cbc)
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeB01AD01
Related LinksN/A